IM Cannabis Corp. (IMCC) stock

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30

$0.57+0.02 (+2.75%)

Close on Nov 13, 2026Market cap $3.35MP/E –Yield –

Earnings

IM Cannabis's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

–

Not yet scheduled

Revenue, Q2 FY2026

C$7.60M

EPS, Q2 FY2026

0.47 CAD

0.09 CAD a year earlier

Latest guidance

None

No outlook given in releases

Quarterly results

Revenue and earnings per share from each of IM Cannabis's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Source
Q2 FY2026ended Jun 30, 2026	Aug 13, 2026after the close	C$7.60M	–	0.47 CAD	Release
Q2 FY2025ended Jun 30, 2025	Aug 12, 2025before the open	–	–	0.09 CAD	Release
Q4 FY2024ended Dec 31, 2024	Mar 31, 2025before the open	C$13.30M	–	-0.32 CAD	Release
Q2 FY2024ended Jun 30, 2024	Aug 14, 2024before the open	C$14.80M	+12.1%	-0.23 CAD	Release
Q2 FY2023ended Jun 30, 2023	Aug 14, 2023before the open	C$13.20M	–	-0.26 CAD	Release
Q4 FY2022ended Dec 31, 2022	Mar 29, 2023before the open	–	–	–	Release
Q2 FY2022ended Jun 30, 2022	Aug 15, 2022during market hours	–	–	–	Release
Q4 FY2021ended Dec 31, 2021	Mar 31, 2022before the open	–	–	–	Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

IM Cannabis has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When IM Cannabis puts a forecast in an earnings release, it is listed here with the exact sentence.